JP2016522243A5 - - Google Patents

Download PDF

Info

Publication number
JP2016522243A5
JP2016522243A5 JP2016520558A JP2016520558A JP2016522243A5 JP 2016522243 A5 JP2016522243 A5 JP 2016522243A5 JP 2016520558 A JP2016520558 A JP 2016520558A JP 2016520558 A JP2016520558 A JP 2016520558A JP 2016522243 A5 JP2016522243 A5 JP 2016522243A5
Authority
JP
Japan
Prior art keywords
silica
hydrogel composite
less
particles
composite according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016520558A
Other languages
English (en)
Japanese (ja)
Other versions
JP6433490B2 (ja
JP2016522243A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2014/050492 external-priority patent/WO2014207304A1/en
Publication of JP2016522243A publication Critical patent/JP2016522243A/ja
Publication of JP2016522243A5 publication Critical patent/JP2016522243A5/ja
Application granted granted Critical
Publication of JP6433490B2 publication Critical patent/JP6433490B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016520558A 2013-06-24 2014-06-18 シリカハイドロゲルコンポジット Active JP6433490B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20135685 2013-06-24
FI20135685 2013-06-24
PCT/FI2014/050492 WO2014207304A1 (en) 2013-06-24 2014-06-18 Silica hydrogel composite

Publications (3)

Publication Number Publication Date
JP2016522243A JP2016522243A (ja) 2016-07-28
JP2016522243A5 true JP2016522243A5 (cg-RX-API-DMAC7.html) 2017-07-20
JP6433490B2 JP6433490B2 (ja) 2018-12-05

Family

ID=51178958

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016520558A Active JP6433490B2 (ja) 2013-06-24 2014-06-18 シリカハイドロゲルコンポジット

Country Status (14)

Country Link
US (1) US9949922B2 (cg-RX-API-DMAC7.html)
EP (1) EP3013317B1 (cg-RX-API-DMAC7.html)
JP (1) JP6433490B2 (cg-RX-API-DMAC7.html)
CN (1) CN105451713B (cg-RX-API-DMAC7.html)
AU (1) AU2014300888B2 (cg-RX-API-DMAC7.html)
CA (1) CA2912483C (cg-RX-API-DMAC7.html)
DK (1) DK3013317T3 (cg-RX-API-DMAC7.html)
ES (1) ES2768606T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20200134T1 (cg-RX-API-DMAC7.html)
HU (1) HUE047897T2 (cg-RX-API-DMAC7.html)
LT (1) LT3013317T (cg-RX-API-DMAC7.html)
PL (1) PL3013317T3 (cg-RX-API-DMAC7.html)
PT (1) PT3013317T (cg-RX-API-DMAC7.html)
WO (1) WO2014207304A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
PL3365020T3 (pl) * 2015-10-22 2020-03-31 Delsitech Oy Preparat depot kompozytu hydrożelowego
FI20155779A7 (fi) 2015-10-30 2017-05-01 Solani Therapeutics Ltd Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu
WO2018102480A1 (en) * 2016-11-30 2018-06-07 Brown University Methods of fabricating hyper compliant polymer particles and methods of use and compositions
CA3088700A1 (en) * 2018-01-23 2019-08-01 Ascend Biopharmaceuticals Ltd Enhanced viral delivery formulation
US20210121534A1 (en) 2018-06-19 2021-04-29 Cella Therapeutics, Llc Sustained-release drug delivery systems comprising an intraocular pressure lowering agent, a cnp compound, an npr-b compound, a tie-2 agonist, or neurotrophic agent for use for treating glaucoma or ocular hypertension
AU2019290582A1 (en) 2018-06-19 2021-01-28 Cella Therapeutics, Llc Drug delivery systems comprising a neurotrophic agent, an apoptosis signaling fragment inhibitor (FAS) or FAS ligand (FASL) inhibitor, a tumor necrosis factor-alpha (TNF-alpha) or TNF receptor inhibitor, a mitochondrial peptide, an oligonucleotide, a chemokine inhibitor, or a cysteine-aspartic protease
KR20200051916A (ko) * 2018-11-05 2020-05-14 주식회사 메디포럼제약 고세렐린을 포함하는 실리카 하이드로겔 조성물
EP4009857B1 (en) * 2019-08-06 2025-08-20 DOSE Medical Corporation Bioerodible cross-linked hydrogel implants and related methods of use
CN111443012B (zh) * 2020-04-09 2021-07-20 华南理工大学 基于复合波等变率温度扫描流变的聚合物凝胶点表征方法
US20230250142A1 (en) 2020-06-12 2023-08-10 Glaxosmithkline Biologicals Sa Dock tag system
WO2022008804A1 (en) 2020-07-07 2022-01-13 Sartar Therapeutics Ltd Silica hydrogel composite and its use
IL301609A (en) * 2020-10-01 2023-05-01 Standard Millox Pharmaceuticals Oy Hydrogel material
US20240197623A1 (en) * 2021-04-07 2024-06-20 Stealth Bio Therapeutics Inc. Silica-based formulations of therapeutic oliogpeptides and peptidomimetics
KR20250092172A (ko) 2022-09-01 2025-06-23 옵티파이 테라퓨틱스 아게 안과용 조성물
AU2024304630A1 (en) 2023-06-15 2025-12-11 Delsitech Oy Injectable composite depot
WO2026083006A1 (en) 2024-10-18 2026-04-23 Delsitech Oy Silica hydrogel composite comprising an active agent
WO2026125822A1 (en) 2024-12-13 2026-06-18 Delsitech Oy Silica hydrogel composite with a water soluble additive

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ332968A (en) * 1996-05-29 2000-08-25 Bioxid Oy A controllably dissolvable silica-xerogel prepared via sol-gel
DE10301669A1 (de) * 2003-01-17 2004-07-29 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Bioaktive keramische Kompositmaterialien und Verfahren zu deren Herstellung
CA2555179A1 (en) 2004-02-27 2005-09-09 Delsitech Oy Method for preparing adjustably bioresorbable sol-gel derived sio2
GB0420016D0 (en) * 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
WO2007135224A2 (en) 2006-05-23 2007-11-29 Delsitech Oy Method for storing silica-based material, package produced with the method and use of package for packaging of silica-based products
FI20070174A0 (fi) 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
US20090324695A1 (en) 2008-05-30 2009-12-31 Paul Ducheyne Biocompatible polymer ceramic composite matrices
KR101068873B1 (ko) 2008-11-28 2011-09-30 연세대학교 산학협력단 바이오마커가 고정된 실리카 나노입자를 함유하는 하이드로젤 및 그 제조방법
US9987225B2 (en) 2009-09-30 2018-06-05 Ottawa Hospital Research Institute Crosslinked hydrogels and related method of preparation

Similar Documents

Publication Publication Date Title
Singh et al. Development of “Smart Foods” for health by nanoencapsulation: Novel technologies and challenges
HRP20200134T1 (hr) Silika hidrogel kompozit
Jansook et al. Cyclodextrins: structure, physicochemical properties and pharmaceutical applications
JP2018500394A5 (cg-RX-API-DMAC7.html)
WO2007027941A3 (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
JP2017537985A5 (cg-RX-API-DMAC7.html)
EA201991299A1 (ru) Приготовление твердых циклодекстриновых комплексов для доставки офтальмологических активных фармацевтических ингредиентов
JP2011509287A5 (cg-RX-API-DMAC7.html)
RU2017101992A (ru) Очищенные терапевтические наночастицы и способы их получения
MX2018012500A (es) Formas de dosificacion de liberacion modificada disuasivas de abuso.
JP2016527890A5 (cg-RX-API-DMAC7.html)
GB2469965A (en) Nanoparticle carriers for drug administration and process for producing same
Roy et al. Combined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approach
MX2019004830A (es) Composiciones farmaceuticas y usos de ellas.
JP2019524724A (ja) テコビリマットの経口用医薬組成物及びその調製法
CY1124635T1 (el) Ξηρες φαρμακευτικες συνθεσεις που περιεχουν νανοσωματιδια ενεργου παραγοντα δεσμευμενα σε σωματιδια φορεα
JP2015520241A5 (cg-RX-API-DMAC7.html)
CN103585113A (zh) 一种芹菜素聚乳酸缓释微球及其制备方法
JP2016113461A5 (cg-RX-API-DMAC7.html)
JP2016535779A5 (cg-RX-API-DMAC7.html)
RU2013103051A (ru) Способ терапии бронхо-констриктивных состояний
IN2013MU01177A (cg-RX-API-DMAC7.html)
IL274149B1 (en) Extended release formulations for intra-articular applications
BR112015015483A2 (pt) forma farmacêutica monolítica para a liberação modificada de uma combinação de ingredientes ativos
CN103976958A (zh) 一种金纳米颗粒在制备抗凝血剂或抗血小板剂中的应用